Skip to main content
Top
Published in: European Journal of Medical Research 1/2021

Open Access 01-12-2021 | Mycobacterium Tuberculosis | Review

Effects of COVID-19 prevention procedures on other common infections: a systematic review

Authors: Omid Dadras, Seyed Ahmad Seyed Alinaghi, Amirali Karimi, Mehrzad MohsseniPour, Alireza Barzegary, Farzin Vahedi, Zahra Pashaei, Pegah Mirzapour, Amirata Fakhfouri, Ghazal Zargari, Solmaz Saeidi, Hengameh Mojdeganlou, Hajar Badri, Kowsar Qaderi, Farzane Behnezhad, Esmaeil Mehraeen

Published in: European Journal of Medical Research | Issue 1/2021

Login to get access

Abstract

Introduction

Since the outbreak of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) began, necessary measures to prevent virus transmission and reduce mortality have been implemented, including mandatory public use of masks, regular hand-sanitizing and hand-washing, social distancing, avoidance of crowds, remote work, and cancellation of public events. During and after the introduction of COVID-19 lockout, we performed a systematic review of available published literature to investigate the incidence of seasonal influenza and other respiratory viral infections.

Methods

PubMed, Embase, Web of Science, Scopus, Science Direct, Google Scholar, Research Gate, and the World Health Organization databases and websites were systematically searched for original studies concerning the impact of COVID-19 prevention means and measures on other common respiratory infectious diseases during the pandemic published by March 2021.

Results

The findings showed that the adherence to health protocols to prevent COVID-19 could help to reduce the incidence of other infectious diseases such as influenza, pneumonia, and Mycobacterium tuberculosis.

Conclusion

The implemented prevention measures and protocols might have reduced the incidence of influenza and some other common respiratory infections. However, controversies exist on this matter and future large population-based studies might provide further information to address these controversies.
Literature
2.
go back to reference Atalan A. Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Ann Med Surg. 2020;56:38–42.CrossRef Atalan A. Is the lockdown important to prevent the COVID-19 pandemic? Effects on psychology, environment and economy-perspective. Ann Med Surg. 2020;56:38–42.CrossRef
3.
go back to reference Oraby T, Tyshenko MG, Maldonado JC, Vatcheva K, Elsaadany S, Alali WQ, et al. Modeling the effect of lockdown timing as a COVID-19 control measure in countries with differing social contacts. Sci Rep. 2021;11(1):1–13.CrossRef Oraby T, Tyshenko MG, Maldonado JC, Vatcheva K, Elsaadany S, Alali WQ, et al. Modeling the effect of lockdown timing as a COVID-19 control measure in countries with differing social contacts. Sci Rep. 2021;11(1):1–13.CrossRef
5.
go back to reference Lee HH, Lin SH. Effects of COVID-19 prevention measures on other common infections, Taiwan. Emerg Infect Dis. 2020;26(10):2509–11.CrossRef Lee HH, Lin SH. Effects of COVID-19 prevention measures on other common infections, Taiwan. Emerg Infect Dis. 2020;26(10):2509–11.CrossRef
6.
go back to reference Kuo S-C, Shih S-M, Chien L-H, Hsiung CA. Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerg Infect Dis. 2020;26(8):1928.CrossRef Kuo S-C, Shih S-M, Chien L-H, Hsiung CA. Collateral benefit of COVID-19 control measures on influenza activity, Taiwan. Emerg Infect Dis. 2020;26(8):1928.CrossRef
7.
go back to reference Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12(1):1–7.CrossRef Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. 2021;12(1):1–7.CrossRef
8.
go back to reference Sakamoto H, Ishikane M, Ueda P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. JAMA. 2020;323(19):1969–71.CrossRef Sakamoto H, Ishikane M, Ueda P. Seasonal influenza activity during the SARS-CoV-2 outbreak in Japan. JAMA. 2020;323(19):1969–71.CrossRef
9.
go back to reference Adlhoch C, Pebody R. What to expect forthe influenza season 2020/21 with the ongoing COVID-19 pandemic in the World Health Organization European Region. Eurosurveillance. 2020;25(42):2001816.CrossRef Adlhoch C, Pebody R. What to expect forthe influenza season 2020/21 with the ongoing COVID-19 pandemic in the World Health Organization European Region. Eurosurveillance. 2020;25(42):2001816.CrossRef
10.
go back to reference Arellanos-Soto D, Padilla-Rivas G, Ramos-Jimenez J, Galan-Huerta K, Lozano-Sepulveda S, Martinez-Acuña N, Treviño-Garza C, Montes-de-Oca-Luna R, de-la-O-Cavazos M, Rivas-Estilla AM. Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19. Sci Rep. 2021;11(1):1-6.. Arellanos-Soto D, Padilla-Rivas G, Ramos-Jimenez J, Galan-Huerta K, Lozano-Sepulveda S, Martinez-Acuña N, Treviño-Garza C, Montes-de-Oca-Luna R, de-la-O-Cavazos M, Rivas-Estilla AM. Decline in influenza cases in Mexico after the implementation of public health measures for COVID-19. Sci Rep. 2021;11(1):1-6..
11.
go back to reference Chan KS, Liang FW, Tang HJ, Toh HS, Yu WL. Collateral benefits on other respiratory infections during fighting COVID-19. Med Clin. 2020;155(6):249–53.CrossRef Chan KS, Liang FW, Tang HJ, Toh HS, Yu WL. Collateral benefits on other respiratory infections during fighting COVID-19. Med Clin. 2020;155(6):249–53.CrossRef
13.
go back to reference Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–88.CrossRef Cowling BJ, Ali ST, Ng TWY, Tsang TK, Li JCM, Fong MW, et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study. Lancet Public Health. 2020;5(5):e279–88.CrossRef
14.
go back to reference Enserink R, Meijer A, Dijkstra F, van Benthem B, van der Steen JT, Haenen A, et al. Absence of influenza A(H1N1) during seasonal and pandemic seasons in a sentinel nursing home surveillance network in the Netherlands. J Am Geriatr Soc. 2011;59(12):2301–5.CrossRef Enserink R, Meijer A, Dijkstra F, van Benthem B, van der Steen JT, Haenen A, et al. Absence of influenza A(H1N1) during seasonal and pandemic seasons in a sentinel nursing home surveillance network in the Netherlands. J Am Geriatr Soc. 2011;59(12):2301–5.CrossRef
15.
go back to reference Galvin CJ, Li YJ, Malwade S, Syed-Abdul S. COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan. Int J Infect Dis. 2020;98:18–20.CrossRef Galvin CJ, Li YJ, Malwade S, Syed-Abdul S. COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan. Int J Infect Dis. 2020;98:18–20.CrossRef
16.
go back to reference Hsu YL, Lin HC, Wei HM, Lai HC, Hwang KP. One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications. Influenza Other Respir Viruses. 2020;14(6):757–8.CrossRef Hsu YL, Lin HC, Wei HM, Lai HC, Hwang KP. One benefit of COVID-19 measures in Taiwan: The reduction of influenza infections and severe complications. Influenza Other Respir Viruses. 2020;14(6):757–8.CrossRef
17.
go back to reference Itaya T, Furuse Y, Jindai K. Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020. Int J Infect Dis. 2020;97:78–80.CrossRef Itaya T, Furuse Y, Jindai K. Does COVID-19 infection impact on the trend of seasonal influenza infection? 11 countries and regions, from 2014 to 2020. Int J Infect Dis. 2020;97:78–80.CrossRef
18.
go back to reference Komiya K, Yamasue M, Takahashi O, Hiramatsu K, Kadota JI, Kato S. The COVID-19 pandemic and the true incidence of Tuberculosis in Japan. J Infect. 2020;81(3):e24–5.CrossRef Komiya K, Yamasue M, Takahashi O, Hiramatsu K, Kadota JI, Kato S. The COVID-19 pandemic and the true incidence of Tuberculosis in Japan. J Infect. 2020;81(3):e24–5.CrossRef
20.
go back to reference Lai CC, Yu WL. The COVID-19 pandemic and tuberculosis in Taiwan. J Infect. 2020;81(2):e159–61.CrossRef Lai CC, Yu WL. The COVID-19 pandemic and tuberculosis in Taiwan. J Infect. 2020;81(2):e159–61.CrossRef
22.
go back to reference Lim RH, Chow A, Ho HJ. Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore. J Infect. 2020;81(6):e19–21.CrossRef Lim RH, Chow A, Ho HJ. Decline in pneumococcal disease incidence in the time of COVID-19 in Singapore. J Infect. 2020;81(6):e19–21.CrossRef
23.
go back to reference Noh JY, Seong H, Yoon JG, Song JY, Cheong HJ, Kim WJ. Social Distancing against COVID-19: implication for the control of influenza. J Korean Med Sci. 2020;35(19):e182.CrossRef Noh JY, Seong H, Yoon JG, Song JY, Cheong HJ, Kim WJ. Social Distancing against COVID-19: implication for the control of influenza. J Korean Med Sci. 2020;35(19):e182.CrossRef
24.
go back to reference Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305–9.CrossRef Olsen SJ, Azziz-Baumgartner E, Budd AP, Brammer L, Sullivan S, Pineda RF, et al. Decreased influenza activity during the COVID-19 pandemic—United States, Australia, Chile, and South Africa, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(37):1305–9.CrossRef
27.
go back to reference Singh S, Ledeboer NA, Laud PW, Hanson R, Truwit JD. Decrease in positivity rate of influenza tests coinciding with outbreak of SARS-CoV-2: data from a Southeastern Wisconsin Laboratory. WMJ. 2020;119(4):275–7.PubMed Singh S, Ledeboer NA, Laud PW, Hanson R, Truwit JD. Decrease in positivity rate of influenza tests coinciding with outbreak of SARS-CoV-2: data from a Southeastern Wisconsin Laboratory. WMJ. 2020;119(4):275–7.PubMed
28.
go back to reference Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg Infect Dis. 2020;26(8):1933–5.CrossRef Soo RJJ, Chiew CJ, Ma S, Pung R, Lee V. Decreased influenza incidence under COVID-19 control measures, Singapore. Emerg Infect Dis. 2020;26(8):1933–5.CrossRef
29.
go back to reference Tan JY, Conceicao EP, Sim XYJ, Wee LEI, Aung MK, Venkatachalam I. Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections. J Hosp Infect. 2020;106(2):387–9.CrossRef Tan JY, Conceicao EP, Sim XYJ, Wee LEI, Aung MK, Venkatachalam I. Public health measures during COVID-19 pandemic reduced hospital admissions for community respiratory viral infections. J Hosp Infect. 2020;106(2):387–9.CrossRef
30.
go back to reference Wong NS, Leung CC, Lee SS. Abrupt subsidence of seasonal influenza after COVID-19 outbreak, Hong Kong, China. Emerg Infect Dis. 2020;26(11):2753–5.CrossRef Wong NS, Leung CC, Lee SS. Abrupt subsidence of seasonal influenza after COVID-19 outbreak, Hong Kong, China. Emerg Infect Dis. 2020;26(11):2753–5.CrossRef
31.
go back to reference Wu D, Lu J, Cao L, Ma X, Liu Q, Liu Y, et al. Positive effects of COVID-19 control measures on pneumonia prevention. IJID . 2020;96:548–9.PubMed Wu D, Lu J, Cao L, Ma X, Liu Q, Liu Y, et al. Positive effects of COVID-19 control measures on pneumonia prevention. IJID . 2020;96:548–9.PubMed
32.
go back to reference Wu D, Lu J, Liu Y, Zhang Z, Luo L. Positive effects of COVID-19 control measures on influenza prevention. Int J Infect Dis. 2020;95:345–6.CrossRef Wu D, Lu J, Liu Y, Zhang Z, Luo L. Positive effects of COVID-19 control measures on influenza prevention. Int J Infect Dis. 2020;95:345–6.CrossRef
33.
go back to reference Wu HJ, Ko NY, Lin WL, Ko WC, Lee NY, Chen PL. Mandatory mask-wearing policy and universal anti-viral treatment mitigate influenza outbreaks during the COVID-19 pandemic. J Microbiol Immunol Infect. 2021;54(1):117–9.CrossRef Wu HJ, Ko NY, Lin WL, Ko WC, Lee NY, Chen PL. Mandatory mask-wearing policy and universal anti-viral treatment mitigate influenza outbreaks during the COVID-19 pandemic. J Microbiol Immunol Infect. 2021;54(1):117–9.CrossRef
35.
go back to reference Seyed Alinaghi S, Oliaei S, Kianzad S, Afsahi AM, Mohsseni Pour M, Barzegary A, et al. Reinfection risk of novel coronavirus (COVID-19): a systematic review of current evidence. World J Virol. 2020;9(5):79–90.CrossRef Seyed Alinaghi S, Oliaei S, Kianzad S, Afsahi AM, Mohsseni Pour M, Barzegary A, et al. Reinfection risk of novel coronavirus (COVID-19): a systematic review of current evidence. World J Virol. 2020;9(5):79–90.CrossRef
36.
go back to reference Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, et al. Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr Med. 2020;40:101226.CrossRef Mehraeen E, Karimi A, Barzegary A, Vahedi F, Afsahi AM, Dadras O, et al. Predictors of mortality in patients with COVID-19-a systematic review. Eur J Integr Med. 2020;40:101226.CrossRef
37.
go back to reference Mehraeen E, Seyed Alinaghi SA, Nowroozi A, Dadras O, Alilou S, Shobeiri P, et al. A systematic review of ECG findings in patients with COVID-19. Indian Heart J. 2020;72(6):500–7.CrossRef Mehraeen E, Seyed Alinaghi SA, Nowroozi A, Dadras O, Alilou S, Shobeiri P, et al. A systematic review of ECG findings in patients with COVID-19. Indian Heart J. 2020;72(6):500–7.CrossRef
40.
go back to reference Güner HR, Hasanoğlu I, Aktaş F. COVID-19: Prevention and control measures in community. Turk J Med Sci. 2020;50:571–7.CrossRef Güner HR, Hasanoğlu I, Aktaş F. COVID-19: Prevention and control measures in community. Turk J Med Sci. 2020;50:571–7.CrossRef
41.
go back to reference Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160(21):3243–7.CrossRef Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160(21):3243–7.CrossRef
43.
go back to reference Aung E, Rao C, Walker S. Teaching cause-of-death certification: lessons from international experience. Postgrad Med J. 2010;86(1013):143–52.CrossRef Aung E, Rao C, Walker S. Teaching cause-of-death certification: lessons from international experience. Postgrad Med J. 2010;86(1013):143–52.CrossRef
44.
go back to reference Pritt BS, Hardin NJ, Richmond JA, Shapiro SL. Death certification errors at an academic institution. Arch Pathol Lab Med. 2005;129(11):1476–9.CrossRef Pritt BS, Hardin NJ, Richmond JA, Shapiro SL. Death certification errors at an academic institution. Arch Pathol Lab Med. 2005;129(11):1476–9.CrossRef
Metadata
Title
Effects of COVID-19 prevention procedures on other common infections: a systematic review
Authors
Omid Dadras
Seyed Ahmad Seyed Alinaghi
Amirali Karimi
Mehrzad MohsseniPour
Alireza Barzegary
Farzin Vahedi
Zahra Pashaei
Pegah Mirzapour
Amirata Fakhfouri
Ghazal Zargari
Solmaz Saeidi
Hengameh Mojdeganlou
Hajar Badri
Kowsar Qaderi
Farzane Behnezhad
Esmaeil Mehraeen
Publication date
01-12-2021
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 1/2021
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/s40001-021-00539-1

Other articles of this Issue 1/2021

European Journal of Medical Research 1/2021 Go to the issue